TARLATAMAB

UNII:	74X82ST8Q1
Formula:
Preferred Substance Name:	TARLATAMAB

2307488-83-9
AMG757
AMG-757
IMDELLTRA
IMMUNOGLOBULIN SCFV-SCFV-SCFC, ANTI-(HOMO SAPIENS DLL3 (DELTA-LIKE LIGAND 3)) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)), MONOCLONAL ANTIBODY SINGLE CHAIN (SCFV)2-SCFC, BISPECIFIC; IG SINGLE CHAIN SCFV-SCFV-SCFC, ANTIDLL3 AND ANTI-CD3E (1-982) (SCFV-VH-V-KAPPA ANTI-DLL3 (1-241) (VH (HOMO SAPIENS IGHV4-59*01 G49>C (44) (96.9%) -(IGHD) -IGHJ4*01 (100%)) CDRIMGT (8.7.12) (26-33.51-57.96-107) (1-118) -15-MER-TRIS(TETRAGLYCYL-SERYL) LINKER (119-133) -V-KAPPA (HOMO SAPIENS IGKV3-20*01 (91.7%) -IGKJ2*01 Q120>C (234) (90.9%)) CDR-IMGT (7.3.9) (160-166.184-186.223-231) (134-241)) -6-MER-SERYL-TETRAGLYCYL-SERYL LINKER (242-247) -SCFV-VH-V-LAMBDA ANTICD3E (248-496) (VH (MUS MUSCULUS IGHV10-1*02 (91.9%) -(IGHD) -IGHJ3*01 (86.7%)/HOMO SAPIENS IGHV3-73*01 (87.0%) -(IGHD) -IGHJ5*01 (100%)) CDR-IMGT (8.10.16) (273-280.298-307.346-361) (248-372)-15-MERTRIS(TETRAGLYCYL-SERYL) LINKER (373-387) -V-LAMBDA (HOMO SAPIENS IGLV7-43*01 (85.1%) -IGLJ3*02 (100%)) CDR-IMGT (9.3.9) (413-421.439-441.478-486) (388-496)) -4-MER-TETRAGLYCYL LINKER (497-500) - SCFC (H-CH2-CH3)-(HCH2-CH3) (501-982) (HOMO SAPIENS IGHG1*03 H-CH2-CH3, NG1M1 (HINGE 6-15 (501-510), CH2 R83>C (572), N84.4>G (577), V85>C (582) (511-620), CH3 E12 (636), M14 (638) (621-725), CHS>DEL) (501-725) -30-MERHEXAKIS(TETRAGLYCYL-SERYL) LINKER (726-755) -HOMO SAPIENS IGHG1*03 H-CH2-CH3, NG1M1 (HINGE 6-15 (756-765), CH2 R83>C (827), N84.4>G (832), V85>C (837) (766-875), CH3 E12 (891), M14 (893) (876-980), CHS (981-982)) (756-982))), PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, NONGLYCOSYLATED
IMMUNOGLOBULIN, ANTI-(HUMAN NOTCH LIGAND DLL3) (HUMAN MONOCLONAL DAELDHWZV-1 SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN MONOCLONAL DAELD-HWZV-1 SINGLE-CHAIN VARIABLE FRAGMENT VH2-(GGGGS)3-VL2) FUSION PROTEIN WITH PEPTIDE LINKER (GGGG) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)6 FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT)
TARLATAMAB [INN]
TARLATAMAB [USAN]
TARLATAMAB [WHO-DD]
TARLATAMAB-DLLE

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TARLATAMAB

Synonyms and Mappings

Resources